In May, the pharmaceutical company agreed to pay $270 million to settle the opioid-related lawsuit filed by Oklahoma.
Purdue Pharma must face accountability for fueling the opioid crisis
In a statement, AG James said, “As Purdue Pharma argues in court that they cannot afford to pay creditors what they owe; the company wants to hand out $38 million in bonuses to their top executives.”
The company needs to be held to account, not be allowed to recklessly spend what they claim are limited funds. Our broad coalition of attorneys general is taking action today to stop this waste from proceeding,” she added.
On the other hand, AG Shapiro commented, “Purdue Pharma and the Sackler family’s greed seem[s] to know no bound. After declaring bankruptcy to try to shield themselves from liability for the opioid epidemic that they engineered, they now want to pay their company executives millions of dollars in bonuses.”
In addition, he emphasized that the pharmaceutical company and the Sackler family generated billions of dollars in profits from OxyContin, the most commonly abused prescription opioid.
